Catheter-directed endovascular application of thrombin: Report of 3 cases and review of the literature
- PMID: 27936421
- PMCID: PMC5499980
- DOI: 10.1016/j.clinimag.2016.11.018
Catheter-directed endovascular application of thrombin: Report of 3 cases and review of the literature
Abstract
Purpose: To report 3 new cases of catheter-directed endovascular application of thrombin and explore trends by analysis of published case series.
Materials and methods: Institutional Review Board approved this retrospective study. All cases of non-tumoral arterial embolization performed from January 2003 to January 2015 at our institution were retrospectively reviewed. Thrombin was used in 7 of 589 cases. In 3 cases intra arterial thrombin was injected via catheter to treat active hemorrhage. Four cases were excluded due to percutaneous injection into visceral pseudoaneurysms (n=3) and making ex vivo autologous clot to be injected via catheter (n=1). Fisher's exact and the Wilcoxon rank sum tests were used to assess for association with acute nontarget thrombosis.
Results: Catheter-directed thrombin was used in 3/589 (0.5%) cases at our institution. All three cases were technically successful with no further bleeding (100%). Nontarget thrombosis of proximal branches occurred in 2 patients (67%) with no significant clinical consequences. Including our 3 cases, a total of 28 cases were reviewed. Of the variables examined-location (p=0.99), size (p=0.66) and etiology of vascular lesion (p=0.92), pseudoaneurysm neck anatomy (p=0.14), thrombin units (p=0.47), volume (p=0.76) or technique of use of small doses (p=0.99), use of other embolic material (p=0.67) and use of adjunct techniques (p=0.99)-none were found to be significantly associated with acute nontarget thrombosis. Technical success was 96% with no reports of reperfusion after treatment.
Conclusions: Catheter-directed endovascular thrombin can be an additional tool to treat pseudoaneurysms not amenable to conventional embolization. Further studies are required to optimize technique and outcomes.
Keywords: Catheter-directed; Endovascular; Pseudoaneurysm; Thrombin; Thrombosis.
Copyright © 2016 Elsevier Inc. All rights reserved.
Figures
References
-
- Bowman LJ, Anderson CD, Chapman WC. Topical recombinant human thrombin in surgical hemostasis. InSeminars in thrombosis and hemostasis. 2010 Jul;36(5):477–484. - PubMed
-
- Clark J, Crean S, Reynolds MW. Topical bovine thrombin and adverse events: a review of the literature. Current medical research and opinion. 2008 Jul 1;24(7):2071–87. - PubMed
-
- Cheng CM, Meyer-Massetti C, Kayser SR. A review of three stand-alone topical thrombins for surgical hemostasis. Clinical therapeutics. 2009 Jan 31;31(1):32–41. - PubMed
-
- Thrombin-JMI [package insert] Bristol, TN: King Pharmaceuticals, Inc.; 2007.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
